it might be due to resource constraints ie personnel, given they need to train surgeons how to use it. Focus on Europe initially makes sense to me given their efforts in Germany atm. I’m pretty sure they have their sights set on other geographic markets, it’s just a matter of time before they can roll-out. Also makes sense to collect info post op from a contained geographic location where Nigel is based atm. Lots of jurisdictions in one region. I think it’s a good approach to start in Europe rather than a tougher regulatory market or a market that is completely foreign ie Asia. I am guessing we will see a future update about other regions in time/at an appropriate time.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)